U.S., EU Move To Harmonize Drug Approval Scheme
Pharmaceutical industry representatives have urged regulators from the United States and the European Union to better harmonize their drug approval and marketing authorization requirements in order to ease the burden on...To view the full article, register now.
Already a subscriber? Click here to view full article